<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04694443</url>
  </required_header>
  <id_info>
    <org_study_id>PI19/00670</org_study_id>
    <nct_id>NCT04694443</nct_id>
  </id_info>
  <brief_title>Multidisciplinary Home-based Tele-rehabilitation Intervention</brief_title>
  <acronym>TeleFall</acronym>
  <official_title>Feasibility and Cost-effectiveness of a Multidisciplinary Home-based Telehealth Intervention Program to Reduce Falls in Parkinson´s Disease (TeleFall).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Esther Cubo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario de Burgos</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Burgos</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitario de Burgos</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Falls in Parkinson's Disease (PD) are very frequent with often devastating consequences,&#xD;
      increasing comorbidity, mortality, decreased quality of life and increased socio-health&#xD;
      costs. In this national, single-center, single-blind, randomized, case-control study,&#xD;
      non-demented patients with idiopathic PD with high risk of falling will be included. The main&#xD;
      objective of this study is to determine the cost-effectiveness of a home-based,&#xD;
      multidisciplinary tele-health intervention to decrease the risk of falling.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, PD patients using multidisciplinary tele-health intervention (study group)&#xD;
      will be compared to age, gender-matched PD patients receiving the best standard in-office&#xD;
      clinical management (control group). Both groups will be followed for 8 months.&#xD;
&#xD;
      The main outcome will be the comparison of incidence of falls between the study and control&#xD;
      groups. Secondary outcomes will include the analysis of cost-effectiveness of&#xD;
      multidisciplinary tele-health interventions.&#xD;
&#xD;
      The results of this study will allow us to study the feasibility of remote health care to&#xD;
      prevent falls in patients with PD, allowing equity in the distribution and access to&#xD;
      specialized health care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Single blind, randomized, case-control study</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The rater will be blind to the patient status (study vs. control).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of falls reduction</measure>
    <time_frame>8 months</time_frame>
    <description>Comparison of incidence of falls between the study and control groups by using diaries and wearable sensors</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility</measure>
    <time_frame>8 months</time_frame>
    <description>Number of virtual videoconferences completed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>8 months</time_frame>
    <description>To compare the medical and non-medical direct costs between the study and control groups by using structured questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healt-related quality of life</measure>
    <time_frame>8 months</time_frame>
    <description>To compare the PDQ-39 scores between the study and control groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Study group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The study group will receive the multidisciplinary tele-health intervention plus standard medical care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The control group will receive the best standard medical care</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Multidisciplinary tele-health intervention (physical therapy, neurologist, nurse, psychologist)</intervention_name>
    <description>Non-pharmacological and pharmacological treatment provided by telemedicine plus in-office visits</description>
    <arm_group_label>Study group</arm_group_label>
    <other_name>Education</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard in-office medical care</intervention_name>
    <description>Non-pharmacological and pharmacological treatment provided in-office visits</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Non-demented patients&#xD;
&#xD;
          -  Patients diagnosed with idiopathic Parkinson´s disease&#xD;
&#xD;
          -  Patients able to walk with a Hoehn Yahr stage &lt; 3&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-ambulatory patients with Parkinson´s disease&#xD;
&#xD;
          -  Patients diagnosed with significant comorbidity (psychiatric, systemic, hearing or&#xD;
             visual disturbances) according to the investigator criteria.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Esther Cubo, MD, PhD</last_name>
    <phone>+34947256533</phone>
    <email>mcubo@saludcastillayleon.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alvaro Garcia Bustillo, OT</last_name>
    <phone>+34947256533</phone>
    <phone_ext>35380</phone_ext>
    <email>alvarogarbu@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitario de Burgos</name>
      <address>
        <city>Burgos</city>
        <zip>09006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Esther Cubo, MD</last_name>
      <phone>+34947256533</phone>
      <phone_ext>35380</phone_ext>
      <email>mcubo@saludcastillayleon.es</email>
    </contact>
    <contact_backup>
      <last_name>Alvaro Garcia Bustillo, OT</last_name>
      <phone>+34947256533</phone>
      <phone_ext>35380</phone_ext>
      <email>alvarogarbu@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 28, 2020</study_first_submitted>
  <study_first_submitted_qc>January 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>January 3, 2021</last_update_submitted>
  <last_update_submitted_qc>January 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario de Burgos</investigator_affiliation>
    <investigator_full_name>Esther Cubo</investigator_full_name>
    <investigator_title>MD, PhD, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Falls</keyword>
  <keyword>Cost-effectiveness</keyword>
  <keyword>Qaly</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>MAIN RESULTS</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

